Search Results - "Yunchao, Huang"

High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis by Qi, Shi-ang, Wu, Qian, Chen, Zhenpu, Zhang, Wei, Zhou, Yongchun, Mao, Kaining, Li, Jia, Li, Yuanyuan, Chen, Jie, Huang, Youguang, Huang, Yunchao

“…Lung cancer is the leading cause of human cancer mortality due to the lack of early diagnosis technology. The low-dose computed tomography scan (LDCT) is one…”
Get full text

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2) by Xu, Jianming, Li, Yi, Fan, Qingxia, Shu, Yongqian, Yang, Lei, Cui, Tongjian, Gu, Kangsheng, Tao, Min, Wang, Xiuwen, Cui, Chengxu, Xu, Nong, Xiao, Juxiang, Gao, Quanli, Liu, Yunpeng, Zhang, Tao, Bai, Yuxian, Li, Wei, Zhang, Yiping, Dai, Guanghai, Ma, Dong, Zhang, Jingdong, Bai, Chunmei, Huang, Yunchao, Liao, Wangjun, Wu, Lin, Chen, Xi, Yang, Yan, Wang, Junye, Ji, Shoujian, Zhou, Hui, Wang, Yan, Ma, Zhuo, Wang, Yanqi, Peng, Bo, Sun, Jiya, Mancao, Christoph

“…This randomized, open-label, multi-center phase 2 study (NCT03116152) assessed sintilimab, a PD-1 inhibitor, versus chemotherapy in patients with esophageal…”
Get full text

YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression by Shi, Yulin, Fan, Songqing, Wu, Mengge, Zuo, Zhixiang, Li, Xingyang, Jiang, Liping, Shen, Qiushuo, Xu, Peifang, Zeng, Lin, Zhou, Yongchun, Huang, Yunchao, Yang, Zuozhang, Zhou, Jumin, Gao, Jing, Zhou, Hu, Xu, Shuhua, Ji, Hongbin, Shi, Peng, Wu, Dong-Dong, Yang, Cuiping, Chen, Yongbin

“…Hypoxia occurs naturally at high-altitudes and pathologically in hypoxic solid tumors. Here, we report that genes involved in various human cancers evolved…”
Get full text

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial by Wu, Yi-Long, Prof, Zhou, Caicun, Prof, Hu, Cheng-Ping, Prof, Feng, Jifeng, Prof, Lu, Shun, Prof, Huang, Yunchao, Prof, Li, Wei, Prof, Hou, Mei, Prof, Shi, Jian Hua, Prof, Lee, Kye Young, Prof, Xu, Chong-Rui, MD, Massey, Dan, MSc, Kim, Miyoung, MD, Shi, Yang, MD, Geater, Sarayut L, MD

“…Summary Background Afatinib—an oral irreversible ErbB family blocker—improves progression-free survival compared with pemetrexed and cisplatin for first-line…”
Get full text

EphA2: A promising therapeutic target in breast cancer by Zhao, Ping, Jiang, Dewei, Huang, Yunchao, Chen, Ceshi

“…Ephrin type-A receptor 2 (EphA2), a receptor tyrosine kinase, is overexpressed in human breast cancers often linked to poor patient prognosis. Accumulating…”
Get full text

Biodegradable Nanofibrillated Cellulose/Poly-(butylene adipate-co-terephthalate) Composite Film with Enhanced Barrier Properties for Food Packaging by Zhou, Xiangyang, Yin, Guoqiang, Huang, Yunchao, Li, Yuan, Xie, Dong

“…Biodegradable composites consisting of Poly-(butylene adipate-co-terephthalate) (PBAT), thermoplastic starch, hydrophobically modified nanofibrillated…”
Get full text

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials by Yang, James Chih-Hsin, Prof, Wu, Yi-Long, Prof, Schuler, Martin, Prof, Sebastian, Martin, MD, Popat, Sanjay, FRCP, Yamamoto, Nobuyuki, Prof, Zhou, Caicun, Prof, Hu, Cheng-Ping, Prof, O'Byrne, Kenneth, Prof, Feng, Jifeng, Prof, Lu, Shun, Prof, Huang, Yunchao, Prof, Geater, Sarayut L, MD, Lee, Kye Young, Prof, Tsai, Chun-Ming, Prof, Gorbunova, Vera, Prof, Hirsh, Vera, Prof, Bennouna, Jaafar, Prof, Orlov, Sergey, Prof, Mok, Tony, Prof, Boyer, Michael, Prof, Su, Wu-Chou, Prof, Lee, Ki Hyeong, Prof, Kato, Terufumi, MD, Massey, Dan, MSc, Shahidi, Mehdi, MD, Zazulina, Victoria, MD, Sequist, Lecia V, MD

“…Summary Background We aimed to assess the effect of afatinib on overall survival of patients with EGFR mutation-positive lung adenocarcinoma through an…”
Get full text

FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century by Huang, Rong, Pu, Yu, Huang, Shun, Yang, Conghui, Yang, Fake, Pu, Yongzhu, Li, Jindan, Chen, Long, Huang, Yunchao

“…Fibroblast activation protein (FAP), a type II transmembrane serine protease, is highly expressed in more than 90% of epithelial tumors and is closely…”
Get full text

Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression by Yang, Binyao, Zhang, Lisha, Cao, Yi, Chen, Shuai, Cao, Jun, Wu, Di, Chen, Jiansong, Xiong, Huali, Pan, Zihua, Qiu, Fuman, Chen, Jinbin, Ling, Xiaoxuan, Yan, Maosheng, Huang, Suli, Zhou, Shiyu, Li, Tiegang, Yang, Lei, Huang, Yunchao, Lu, Jiachun

“…Reprogrammed energy metabolism as an emerging hallmark of cancer has recently drawn special attention since it facilitate cell growth and proliferation…”
Get full text

MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB by Yongchun, Zhou, Linwei, Tian, Xicai, Wang, Lianhua, Ye, Guangqiang, Zhao, Ming, Yu, Guanjian, Li, Yujie, Lei, Yunchao, Huang

“…Abstract MicroRNA-195 (miR-195) has been implicated in several other cancers; however, its role in non-small cell lung cancer (NSCLC) remains unclear. In this…”
Get full text

Effects of lipid emulsions on the formation of Escherichia coli–Candida albicans mixed-species biofilms on PVC by Li, Shanshan, Duan, Wanshi, Lei, Yujie, Wang, Zhonghui, Fu, Chaojiang, He, Liang, Shen, Zhenghai, Li, Minjie, Chen, Ying, Huang, Yunchao

“…Patients receiving lipid emulsions are at increased risk of contracting catheter-related bloodstream infections (CRBSIs) in the clinic. More than 15% of CRBSIs…”
Get full text

Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis by Shen, Zhenglei, Gu, Xuezhong, Mao, Wenwen, Yin, Liefen, Yang, Ling, Zhang, Zhe, Liu, Kunmei, Wang, Lilan, Huang, Yunchao

“…This meta-analysis was performed to explore the impact of minimal residual disease (MRD) prior to transplantation on the prognosis for patients with acute…”
Get full text

Mxi1 participates in the progression of lung cancer via the microRNA-300/KLF9/GADD34 Axis by Lei, Yujie, Huang, Yunchao, Lin, Jianbin, Sun, Shihui, Che, Keda, Shen, Junting, Liao, Jun, Chen, Yangming, Chen, Kai, Lin, Zhaoxian, Lin, Xing

“…The purpose of the current study was to define the role of MAX interactor 1 (Mxi1) in the pathogenesis of lung cancer and its underlying molecular mechanism…”
Get full text

Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells by Duan, Lincan, Shen, Hongmei, Zhao, Guangqiang, Yang, Runxiang, Cai, Xinyi, Zhang, Lijuan, Jin, Congguo, Huang, Yunchao

“…•Disulfiram and copper synergistically inhibit lung cancer cell proliferation.•Lung cancer cell colony formation ability is inhibited by…”
Get full text

The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry by Liu, Xujun, Si, Wenzhe, He, Lin, Yang, Jianguo, Peng, Yani, Ren, Jie, Liu, Xiaoping, Jin, Tong, Yu, Huajing, Zhang, Zihan, Cheng, Xiao, Zhang, Wenting, Xia, Lu, Huang, Yunchao, Wang, Yue, Liu, Shumeng, Shan, Lin, Zhang, Yu, Yang, Xiaohan, Li, Haixia, Liang, Jing, Sun, Luyang, Shang, Yongfeng

“…The scope and variety of the metabolic intermediates from the mitochondrial tricarboxylic acid (TCA) cycle that are engaged in epigenetic regulation of the…”
Get full text

Constituents of Household Air Pollution and Risk of Lung Cancer among Never-Smoking Women in Xuanwei and Fuyuan, China by Vermeulen, Roel, Downward, George S, Zhang, Jinming, Hu, Wei, Portengen, Lützen, Bassig, Bryan A, Hammond, S Katharine, Wong, Jason Y Y, Li, Jihua, Reiss, Boris, He, Jun, Tian, Linwei, Yang, Kaiyun, Seow, Wei Jie, Xu, Jun, Anderson, Kim, Ji, Bu-Tian, Silverman, Debra, Chanock, Stephen, Huang, Yunchao, Rothman, Nathaniel, Lan, Qing

“…Lung cancer rates among never-smoking women in Xuanwei and Fuyuan in China are among the highest in the world and have been attributed to the domestic use of…”
Get full text

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6 by Wu, Yi-Long, Sequist, Lecia V, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Schuler, Martin, Mok, Tony, Yamamoto, Nobuyuki, O'Byrne, Kenneth, Hirsh, Vera, Gibson, Neil, Massey, Dan, Kim, Miyoung, Yang, James Chih-Hsin

“…Background: In the Phase III LUX-Lung 3/6 (LL3/LL6) trials in epidermal growth factor receptor ( EGFR ) mutation-positive lung adenocarcinoma patients, we…”
Get full text

The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis by Ma, Mingsheng, Cao, Run, Wang, Wei, Wang, Biying, Yang, Yichen, Huang, Yunchao, Zhao, Guangqiang, Ye, Lianhua

“…Abstract Objective Although the significance of increased plasma D-dimer levels in activating coagulation and fibrinolysis has been reported, it is still…”
Get full text

Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer by Ran, Hailiang, Ma, Jie, Cai, Le, Zhou, Hai, Yuan, Zhongqin, Chen, Ying, Chang, Wei, Huang, Yunchao, Xiao, Yuanyuan

“…Serum cholinesterase (ChE) was found to be involved in cancer initiation and progression. However, the survival association between serum ChE and non-small…”
Get full text

CAR‐T cell therapy for lung cancer: Potential and perspective by Chen, Long, Chen, Fukun, Li, Jindan, Pu, Yongzhu, Yang, Conghui, Wang, Yue, Lei, Yujie, Huang, Yunchao

“…Lung cancer is the highest incidence and mortality of all cancers around the world. In the present immunotherapy era, an increasing number of immunotherapeutic…”
Get full text